DSpace

Digital.CSIC >

Browsing by Author Artigas, Francesc

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
 
Showing results 174 to 193 of 261
Issue DateTitleAuthor(s)Type
Feb-1993p-Chlorophenylalanine increases tryptophan hydroxylase mRNA levels in the raphe nuclei. A time course study using in situ hybridization.Cortés, Roser; Mengod Los Arcos, Guadalupe; Celada, Pau; Artigas, FrancescArtículo
2010Pharmacological Treatment of HallucinationsSanjuán, Julio; Aguilar, Eduardo J.; Artigas, FrancescCapítulo de libro
15-Jul-2014Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorderÁlvarez, Enric; Pérez, Víctor; Artigas, FrancescArtículo
8-Oct-2013Phencyclidine activates thalamocortical networks by inhibiting GABAergic neurons in the reticular nucleus of the thalamusTroyano-Rodriguez, Eva; Santana, Noemí; Lladó-Pelfort, Laia; Artigas, Francesc; Celada, PauPóster
Jul-2009Pindolol augmentation enhances response outcomes in first depressive episodesPortella, Maria J.; Artigas, Francesc; Pérez, VíctorArtículo
Feb-2006Pindolol augmentation of antidepressant responseArtigas, Francesc; Adell, Albert; Celada, PauArtículo
1994Pindolol induce una mejoría rápida en pacientes depresivos tratados con inhibidores de la captación de serotoninaArtigas, Francesc; Pérez, Víctor; Álvarez, EnricArtículo
Mar-1994Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitorsArtigas, Francesc; Pérez, Víctor; Álvarez, EnricArtículo
Nov-1995Pindolol, 5-hydroxytryptamine and antidepressant augmentationArtigas, FrancescArtículo
Dec-1993Plasma 5-hydroxyindoleacetic acid as an indicator of MAO-A inhibition in brain and peripheral tissuesCelada, Pau; Artigas, FrancescArtículo
1990Poliaminas y lesión neurológicaMartínez, Emili; Artigas, Francesc; Vera, Núria de; Camón, LLuïsa; Serratosa, JoanArtículo
17-Jul-2012Post-transcriptional modulation of serotonin transporter as a new target for antidepressant therapyBortolozzi, Analía; Ferrés-Coy, Albert; Pilar-Cuéllar, Fuencisla; Vidal, R.; Paz, V.; Cortés, Roser; Masana, M.; Valdizán, Elsa M.; Pazos, Ángel; Artigas, FrancescPóster
14-May-1999Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortexCasanovas, Josep M.; Hervás, Ildefonso; Artigas, FrancescArtículo
1995Potenciación del efecto de los antidepresivos serotoninérgicos mediante antagonistas 5-HT1A: estudio abierto con pindololPérez, Víctor; Romero, Luz; Pérez-Blanco, J.; Bel, Nuria; Álvarez, Enric; Artigas, FrancescArtículo
2012Preclinical and clinical characterization of the selective 5-HT 1A receptor antagonist DU-125530 for antidepressant treatmentScorza, María Cecilia; Lladó-Pelfort, Laia; Cortés, Roser; Celada, Pau; Artigas, FrancescArtículo
2013Preclinical models of schizophreniaFrazer, Alan; Artigas, FrancescArtículo
Aug-2010Preferential in vivo action of F15599, a novel 5-HT1A receptor agonist, at postsynaptic 5-HT1A receptorsLladó-Pelfort, Laia; Artigas, Francesc; Celada, PauArtículo
Jun-1997Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptorsRomero, Luz; Artigas, FrancescArtículo
4-Feb-2008Prefrontal cortex lesions cause only minor effects on the hyperlocomotion induced by MK-801 and its reversal by clozapineScorza, María Cecilia; Artigas, FrancescArtículo
15-Aug-1999Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depressionFigueras, Gloria; Pérez, Víctor; San Martino, Olga; Álvarez, Enric; Artigas, FrancescArtículo

Showing results 174 to 193 of 261